Health · 3 views
Next-Generation Oral SERD Approved for Breast Cancer
(MedPage Today) -- The FDA approved the next-generation oral selective estrogen receptor degrader (SERD) giredestrant (Wilserdly) in combination with everolimus for previously treated estrogen receptor (ER)-positive, HER2-negative…
Summary
(MedPage Today) -- The FDA approved the next-generation oral selective estrogen receptor degrader (SERD) giredestrant (Wilserdly) in combination with everolimus for previously treated estrogen receptor (ER)-positive, HER2-negative, ESR1-mutated
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- New tool enables early intervention for diabetic foot ulcersContinue reading
- U.S. officially loses measles elimination status: "What a tragedy"Continue reading
- US loses measles elimination status amid worst outbreak since 1991Continue reading
- U.S. loses measles elimination status, marking embarrassing stain on its public health recordContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow